Business
TGA proposes over-the-counter sales of CBD products – Small Caps
In a move that would appear to enthuse the ASX-listed cannabis stocks, the Therapeutic Goods Administration (TGA) has announced an interim decision to reclassify cannabidiol (CBD) products so they can be purchased over the counter at pharmacies.
In a move that would appear to enthuse the ASX-listed cannabis stocks, the Therapeutic Goods Administration (TGA) has announced an interim decision to reclassify cannabidiol (CBD) products so they can be purchased over the counter at pharmacies.
The TGAs provisional ruling entails the down-scheduling of low dose CBD products from Schedule 4 to Schedule 3 of the Poisons Standard. This means companies can apply to register their applicable products to be available through a pharmacist, without th…
-
Business17 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today
-
Noosa News15 hours agoPill checking to resume in Queensland months after government axed funding
-
Business19 hours agoASX shares are expensive. Here’s why you should be buying anyway
-
Noosa News23 hours agoThe Full Trailer for Yorgos Lanthimos’ Emma Stone-Led CEO-Kidnapping Dark Comedy ‘Bugonia’ Is Here